This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here
Collateral flex option is for companies with large deductible policies in US
CAS paper provides pricing and valuation models
More ILS than ILW
Low interest rates are prompting insurers to look to further afield in their hunt for yield. For those with resources and dedication, two major areas of focus right now are corporate loans and infrastructure lending. But are these the assets of the future that many say they are? Sarfraz Thind reports
Liquidity swaps can give insurers collateralised exposure to higher-yielding assets and ease the pressure on investment performance. But does the yield pick-up compensate for the complexities of the market?
Securitisations, hedge funds, real estate and private equity are not favoured assets based on Solvency II capital charges, but derivatives may offer insurers some flexibility, as Safraz Thind explains
Aegon's €12bn longevity swap last month appeared to be the deal that would finally kick-start the heavily-hyped longevity risk transfer business. But the finer details reveal more marketing spin than substance. Sarfraz Thind investigates
Insurers are facing challenges on both sides of the balance sheet from the market environment and regulatory change. New approaches are needed but there are pitfalls. Helen Yates explains
Eiopa's insurance stress tests have come under fire, and with Solvency II still in development are they out of date already? Lorna Davies reports.